Canonsburg, Pennsylvania-based Viatris Inc. (VTRS) is a global pharmaceutical company focused on making medicines more accessible, with a portfolio spanning generic, complex generic, branded, and innovative medicines. With a market cap of $10.4 billion, Viatris serves patients across 165+ countries and territories and covers more than 10 major therapeutic areas, including cardiovascular disease, oncology, diabetes, respiratory health, and infectious diseases.
Companies worth $10 billion or more are generally described as "large-cap stocks." Viatris fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the specialty & generic drug manufacturing industry.
